188 filings
Page 3 of 10
PRE 14A
IKT
Inhibikase Therapeutics Inc
Preliminary proxy
21 Apr 23
4:30pm
EFFECT
IKT
Inhibikase Therapeutics Inc
5 Apr 23
Notice of effectiveness
12:15am
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
10-K
2022 FY
IKT
Inhibikase Therapeutics Inc
Annual report
31 Mar 23
7:10am
8-K
IKT
Inhibikase Therapeutics Inc
22 Mar 23
Regulation FD Disclosure
4:04pm
8-K
IKT
Inhibikase Therapeutics Inc
13 Mar 23
Other Events
5:26pm
8-K
IKT
Inhibikase Therapeutics Inc
6 Mar 23
Departure of Directors or Certain Officers
4:55pm
4
IKT
Inhibikase Therapeutics Inc
3 Mar 23
Inhibikase Therapeutics / Milton H. Werner ownership change
5:00pm
4
IKT
Inhibikase Therapeutics Inc
3 Mar 23
Inhibikase Therapeutics / JOSEPH FRATTAROLI ownership change
5:00pm
SC 13D
IKT
Inhibikase Therapeutics Inc
24 Feb 23
Inhibikase Therapeutics / FiveT Investment Management ownership change
12:27pm
SC 13G/A
Milton H. Werner
16 Feb 23
Inhibikase Therapeutics / Werner Milton H. ownership change
12:00am
424B3
IKT
Inhibikase Therapeutics Inc
8 Feb 23
Prospectus supplement
9:13am
EFFECT
IKT
Inhibikase Therapeutics Inc
8 Feb 23
Notice of effectiveness
12:15am
D
IKT
Inhibikase Therapeutics Inc
7 Feb 23
$4.20 mm in options / securities to be acquired, sold $4.20 mm, 1 investor
4:48pm
UPLOAD
IKT
Inhibikase Therapeutics Inc
3 Feb 23
Letter from SEC
12:00am
CORRESP
IKT
Inhibikase Therapeutics Inc
3 Feb 23
Correspondence with SEC
12:00am
S-1
IKT
Inhibikase Therapeutics Inc
IPO registration
1 Feb 23
9:02pm
SC 13D
FiveT Investment Management Ltd
31 Jan 23
Inhibikase Therapeutics / FiveT Investment Management ownership change
11:59am
424B5
IKT
Inhibikase Therapeutics Inc
27 Jan 23
Prospectus supplement for primary offering
8:25am